• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia

    New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia

  2. Dyax Shares Jump as Angioedema Drug Shows Promise

    Dyax Shares Jump as Angioedema Drug Shows Promise

  3. Orthofix International Secures Option to Acquire eNeura, Inc.

    Orthofix International Secures Option to Acquire eNeura, Inc.

  4. Fujifilm Holdings to Acquire Cellular Dynamics International, Inc.

    Fujifilm Holdings to Acquire Cellular Dynamics International, Inc.

  5. GenSpera Launches National Investor Relations Program

    GenSpera Launches National Investor Relations Program

  6. Dyax shares jump 40% on 'best-in-class' potential for new drug

    Dyax shares jump 40% on 'best-in-class' potential for new drug

  7. UPDATE: Analog Devices gains on upgrade; Altera slides

    UPDATE: Analog Devices gains on upgrade; Altera slides

  8. Severe Alzheimer's Patient Responds to Bryostatin Treatment

    Severe Alzheimer's Patient Responds to Bryostatin Treatment

  9. DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study

    DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study

  10. Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer

    Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.